ID
DORM icon

Integral Derivatives’s Dorman Products DORM Stock Holding History

Integral Derivatives’s Portfolio DORM Stock Details DORM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,000
Closed -$740K – 1422
2014
Q2 		$740K Buy
+15,000
New +$818K 0.01% 794

Other funds holding DORM

TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return

Integral Derivatives's DORM Position: Q3 2014 in Review

Integral Derivatives sold out of Dorman Products (DORM) in Q3 2014, closing a stake of 10,500 shares — an estimated $518K sold.

Integral Derivatives first reported a position in DORM in Q2 2014 and held it in 1 quarter. The position peaked at $518K in Q2 2014. 167 funds tracked by Wall St. Rank hold DORM as of Q3 2014.

  • Integral Derivatives reported no remaining Dorman Products position as of Q3 2014 after selling out during the quarter.
  • Integral Derivatives sold 10,500 Dorman Products shares in Q3 2014, an estimated $518K.
  • Integral Derivatives first reported a position in Dorman Products in Q2 2014 and held it in 1 quarter.
  • Integral Derivatives's Dorman Products position peaked at $518K in Q2 2014.
  • 167 funds tracked by Wall St. Rank held Dorman Products as of Q3 2014.

Based on Integral Derivatives's 13F filing for Q3 2014, filed 6 Oct 2014.